References
- COPD Prevalence | American Lung Association. Accessed May 1, 2021. https://www.lung.org/research/trends-in-lung-disease/copd-trends-brief/copd-prevalence.
- National Institutes of Health. National Heart, Lung, and Blood, Institute. Morbidity & mortality: 2012 Chart book on cardiovascular, lung, and blood diseases. National Institutes of Health
- CDC. Age-standardized death rates for chronic obstructive pulmonary disease (COPD) – United States, 1999–2014; 1999. Accessed May 1, 2021. http://wonder.cdc.gov.
- Chronic Obstructive Pulmonary Disease – Level 3 cause | Institute for Health Metrics and Evaluation. Accessed September 5, 2021. http://www.healthdata.org/results/gbd_summaries/2019/chronic-obstructive-pulmonary-disease-level-3-cause.
- 2021 GOLD Reports – Global Initiative for Chronic Obstructive Lung Disease – GOLD. Accessed April 10, 2021. https://goldcopd.org/2021-gold-reports/.
- Chronic Obstructive Pulmonary Disease Surveillance –- United States, 1971–2000. Accessed April 10, 2021. https://www.cdc.gov/mmWR/preview/mmwrhtml/ss5106a1.htm.
- Halbert RJ, Isonaka S, George D, et al. Interpreting COPD prevalence estimates: what is the true burden of disease? Chest. 2003;123(5):1684–1692. DOI:https://doi.org/10.1378/chest.123.5.1684
- COPD Burden | American Lung Association. Accessed April 10, 2021. https://www.lung.org/research/trends-in-lung-disease/copd-trends-brief/copd-burden.
- Barnes PJ. Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med. 2010;7(3):e1000220–4. DOI:https://doi.org/10.1371/journal.pmed.1000220
- Naik D, Joshi A, Paul TV, et al. Chronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threat. Ind J Endocrinol Metab. 2014;18(5):608–616. DOI:https://doi.org/10.4103/2230-8210.139212
- Lopez AD, Shibuya K, Rao C, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412. DOI:https://doi.org/10.1183/09031936.06.00025805
- Jinjuvadia C, Jinjuvadia R, Mandapakala C, et al. Trends in outcomes, financial burden, and mortality for acute exacerbation of chronic obstructive pulmonary disease (COPD) in the United States from 2002 to 2010. J Chronic Obstr Pulm Dis. 2017;14(1):72–79. DOI:https://doi.org/10.1080/15412555.2016.1199669
- Wedzicha JA, Singh R, Mackay AJ. Acute COPD exacerbations. Published online 2014. DOI:https://doi.org/10.1016/j.ccm.2013.11.001
- Donaldson GC, Seemungal TAR, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852. DOI:https://doi.org/10.1136/thorax.57.10.847
- Goel K, Bailey M, Borgstrom M, et al. Trends in chronic obstructive pulmonary disease hospitalization and in-hospital deaths in the United States by sex: 2005 to 2014. Ann Am Thorac Soc. 2019;16(3):391–393. DOI:https://doi.org/10.1513/AnnalsATS.201807-488RL
- NEDS Overview. Accessed May 7, 2021. https://www.hcup-us.ahrq.gov/nedsoverview.jsp.
- HCUP-US Home Page. Accessed May 7, 2021. https://hcup-us.ahrq.gov/.
- Díez J de M, Morgan JC, García RJ. The association between COPD and heart failure risk: a review. Int J Chron Obstruct Pulmon Dis. 2013;8:305–312. DOI:https://doi.org/10.2147/COPD.S31236
- Gautam SS, O’Toole RF. Convergence in the epidemiology and pathogenesis of COPD and pneumonia. J Chronic Obstr Pulm Dis. 2016;13(6):790–798. DOI:https://doi.org/10.1080/15412555.2016.1191456
- Aleva FE, Voets LWLM, Simons SO, et al. Prevalence and localization of pulmonary embolism in unexplained acute exacerbations of COPD: a systematic review and Meta-analysis. Chest. 2017;151(3):544–554. DOI:https://doi.org/10.1016/j.chest.2016.07.034
- Yang M, Du Y, Chen H, et al. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: a meta-analysis of randomized controlled trials. Int Immunopharmacol. 2019;77 doi:https://doi.org/10.1016/j.intimp.2019.
- Ford ES. Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001–2012 and nationwide emergency department sample 2006–2011. Chest. 2015;147(4):989–998. DOI:https://doi.org/10.1378/chest.14-2146
- Singh JA, Yu S. Utilization due to chronic obstructive pulmonary disease and its predictors: a study using the U.S. National Emergency Department Sample (NEDS). Respir Res. 2016;17(1):1 DOI:https://doi.org/10.1186/s12931-015-0319-y
- Gentzke AS, Creamer M, Cullen KA, et al. Vital signs: Tobacco product use among Middle and high school students – United States, 2011–2018. Morb Mortal Wkly Rep. 2019;68(6):157–164. DOI:https://doi.org/10.15585/mmwr.mm6806e1
- Cullen KA, Gentzke AS, Sawdey MD, et al. e-Cigarette use among youth in the United States, 2019. J Am Med Assoc. 2019;322(21):2095–2103. DOI:https://doi.org/10.1001/jama.2019.18387
- Patterns of Tobacco Use Among U.S. Youth, Young Adults, and Adults – The Health Consequences of Smoking – 50 Years of Progress – NCBI Bookshelf. Accessed August 24, 2021. https://www.ncbi.nlm.nih.gov/books/NBK294302/?report=reader.
- Mannino DM, Homa DM, Akinbami LJ, et al. Chronic obstructive pulmonary disease surveillance–United States, 1971-2000. Respir Care. 2002;47(10):1184–1199.
- Current Cigarette Smoking Among Adults in the United States | CDC. Accessed May 1, 2021. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/adult_data/cig_smoking/index.htm.
- Tobacco Trends Brief | American Lung Association. Accessed May 1, 2021. https://www.lung.org/research/trends-in-lung-disease/tobacco-trends-brief/overall-tobacco-trends.
- COPD Risk Factors and Patient Characteristics | American Lung Association. Accessed April 12, 2021. https://www.lung.org/research/trends-in-lung-disease/copd-trends-brief/copd-risk-factors.
- WHO | Projections of mortality and causes of death, 2016 to 2060. WHO. Published online 2018. Accessed April 12, 2021. http://www.who.int/healthinfo/global_burden_disease/projections/en/.
- Ford ES. Trends in mortality from COPD among adults in the United States. Chest. 2015;148(4):962–970. DOI:https://doi.org/10.1378/chest.14-2311
- Genao L, Durheim MT, Mi X, et al. Early and long-term outcomes of older adults after acute care encounters for chronic obstructive pulmonary disease exacerbation. Ann Am Thorac Soc. 2015;12(12):1805–1812. DOI:https://doi.org/10.1513/AnnalsATS.201504-250OC
- Vestbo J, Anderson JA, Calverley PMA, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943. DOI:https://doi.org/10.1136/thx.2009.113662
- Puhan MA, Gimeno-Santos E, Scharplatz M, et al. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. In: Cochrane database of systematic reviews. Wiley; 2011. DOI:https://doi.org/10.1002/14651858.cd005305.pub3
- Murphy PB, Rehal S, Arbane G, et al. Effect of home noninvasive ventilation with oxygen therapy vs oxygen therapy alone on hospital readmission or death after an acute COPD exacerbation: a randomized clinical trial. J Am Med Assoc. 2017;317(21):2177–2186. DOI:https://doi.org/10.1001/jama.2017.4451
- Kvale PA, Conway WA, Coates EO. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. . Ann Intern Med. 1980;93(3):391–398. DOI:https://doi.org/10.7326/0003-4819-93-3-391
- Qaseem A. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med. 2011;155(3):179. DOI:https://doi.org/10.7326/0003-4819-155-3-201108020-00008
- Rothnie KJ, Yan R, Smeeth L, et al. Risk of myocardial infarction (MI) and death following MI in people with chronic obstructive pulmonary disease (COPD): a systematic review and Meta-analysis. BMJ Open. 2015;5(9):e007824 DOI:https://doi.org/10.1136/bmjopen-2015-007824
- Mannino DM, Thorn D, Swensen A, et al. Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD. Eur Respir J. 2008;32(4):962–969. DOI:https://doi.org/10.1183/09031936.00012408
- Sin DD, Paul Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11):1514–1519. DOI:https://doi.org/10.1161/01.CIR.0000056767.69054.B3
- Grymonprez M, Vakaet V, Kavousi M, et al. Chronic obstructive pulmonary disease and the development of atrial fibrillation. Int J Cardiol. 2019;276:118–124. DOI:https://doi.org/10.1016/j.ijcard.2018.09.056
- Terzano C, Romani S, Conti V, et al. Atrial fibrillation in the acute, hypercapnic exacerbations of COPD. Eur Rev Med Pharmacol Sci. 2014;18:2908–17.
- Barshes NR, Goodpastor SE, Goss JA. Pharmacologic immunosuppression. Front Biosci. 2004;9:411–420. DOI:https://doi.org/10.2741/1249
- Boersma WG. Antibiotics in acute exacerbations of COPD: the good, the bad and the ugly. Eur Respir J. 2012;40(1):1–3. DOI:https://doi.org/10.1183/09031936.00211911
- Frost A, Badesch D, Gibbs JS, et al. Diagnosis of pulmonary hypertension. Eur Resp J. 2019;53:1801904.. DOI:https://doi.org/10.1183/13993003.01904-2018
- McAvay GJ, Vander Wyk B, Allore H. Individual heterogeneity in the probability of hospitalization, skilled nursing facility admission, and mortality. J Gerontol Ser A. 2021;76(9):1668–1677. DOI:https://doi.org/10.1093/gerona/glaa314
- Hawkins NM, Petrie MC, Jhund PS, et al. Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail. 2009;11(2):130–139. DOI:https://doi.org/10.1093/eurjhf/hfn013
- Iheanacho I, Zhang S, King D, et al. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–460. DOI:https://doi.org/10.2147/COPD.S234942